Allied Biotech Corporation (TPEX:1780)

Allied Biotech Revenue

In the year 2025, Allied Biotech had annual revenue of 849.51M TWD with 5.28% growth. Allied Biotech had revenue of 213.92M in the quarter ending December 31, 2025, with 14.88% growth.

• Revenue: 849.51M
• Revenue Growth: +5.28%
• P/S Ratio: 3.08
• Revenue / Employee: 21.24M
• Employees: 40
• Market Cap: 2.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	849.51M	42.59M	5.28%
Dec 31, 2024	806.92M	86.49M	12.00%
Dec 31, 2023	720.43M	3.69M	0.51%
Dec 31, 2022	716.75M	39.99M	5.91%
Dec 31, 2021	676.76M	58.69M	9.50%